Circassia Pharmaceuticals Financial Overview
Circassia Pharmaceuticals's market cap is currently £281.65M. The company's EPS TTM is p0.014; its P/E ratio is 53.49; and it has a dividend yield of 3.34%. Circassia Pharmaceuticals is scheduled to report earnings on September 30, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
